2020年肾脏病学研究进展系列—基础领域研究热点
1.足细胞研究进展
参考文献
1.Unnersjo-Jess, D., et al., A Fast and Simple Clearing and Swelling Protocol for 3D In-Situ Imaging of the Kidney across Scales. Kidney Int, 2020.
2.Meyer-Schwesinger, C., et al., A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients. Kidney Int, 2020. 97(5): p. 913-919.
2.肾脏疾病中的代谢重编程
参考文献
1.Jing, C. and T. Castro-Dopico, Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis. 2020. 117(26): p. 15160-15171.
2.Fu, Y., et al., Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism. Cell Metab, 2020. 32(6): p. 1052-1062.e8.
3.Hasegawa, S., et al., The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease. Kidney Int, 2020. 97(5): p. 934-950.
3.人工智能在肾脏疾病诊疗中的应用
参考文献
1.Rashidi P, Bihorac A. Artificial intelligence approaches to improve kidney care.Nat Rev Nephrol. 2020 Feb;16(2):71-72.
2.Song X, Yu ASL, Kellum JA, et al.Cross-site transportability of an explainable artificial intelligence model for acute kidney injury prediction.Nat Commun. 2020 Nov ;11(1):5668.
3.Schena FP, Anelli VW, Trotta J, et al. Development and testing of an artificial intelligence tool for predicting end stage kidney disease in patients with immunoglobulin A nephropathy. Kidney Int. 2020 Sep 1;S0085-2538(20)30969-8.
4.Ligabue G, Pollastri F, Fontana F, et al. Evaluation of the classification accuracy of the kidney biopsy direct immunofluorescence through convolutional neural networks. Clin J Am Soc Nephrol. 2020 Oct 7;15(10): 1445–1454.
5.Hou J and Nast CC. Artificial Intelligence The Next Frontier in Kidney Biopsy Evaluation. Clin J Am Soc Nephrol, 2020 Oct 7;15(10):1389-1391.
4.COVID-19肾损伤机制
参考文献
1.Naicker, S. et al. The novel coronavirus 2019 epidemic and kidneys. Kidney Int. 97, 824–828 (2020).
2.Wu, C. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumoniain Wuhan, China. JAMA Intern. Med. https://doi.org/10.1001/jamainternmed. (2020).
3.Cheng, Y. et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 97, 829–838 (2020).
4.Cummings, M. J. et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 395, 1763–1770 (2020).
5.Hirsch, J.S. et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. https://doi.org/10.1016/j.kint(2020).
6.Wan EY, et al. Extrapulmonary manifestations of COVID-19. Nat Med.1017-1032. doi: 10.1038/s41591-020-0968-3(2020).
7.Helms, J. et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. https://doi.org/10.1007/s00134-020-06062-x (2020).
8.Shetty A. et al. COVID-19-Associated Glomerular Disease. J Am Soc Nephrol. Nov 19:ASN.2020060804. doi: 10.1681/ASN.2020060804. Online ahead of print(2020).
9.Friedman, D. J. & Pollak, M. R. APOL1 and kidney disease: from genetics to biology. Annu. Rev. Physiol. 82, 323–342 (2020).
联系客服